Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Pharmacokinetic Study to Assess the Age-dependency in the Clearance of Doxorubicin in Paediatric Patients With Solid Tumours and Leukaemia

NCT01095926 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.

NCT NCT01095926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01095926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Pharmacokinetic Study to Assess the Age-dependency in the Clearance of Doxorubicin in Paediatric Patients With Solid Tumours and Leukaemia
Lead sponsor
University Hospital Muenster
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
May 31, 2013
Enrollment
101 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, neuroblastoma, soft tissue sarcoma, wilms tumor